EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanosuspension and Microenvironmental pH Modification to Enhance Atorvastatin Dissolution in Fixed-Dose Combination Ezetimibe/Atorvastatin Tablets

Deny Puriyani Azhary, Yuda Prasetya Nugraha, Rachmat Mauludin

Biophysica · 19.05.2026 · 6 (3) · 44

DOI: 10.3390/biophysica6030044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysica, online erschienen am 19.05.2026. Verfasst von Deny Puriyani Azhary und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indonesia Endowment Fund for Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Fixed-dose combination (FDC) therapy of ezetimibe (EZT) and atorvastatin (ATV) is increasingly prescribed for high-risk hyperlipidemic patients with cardiovascular disease. However, the pharmaceutical production of FDC EZT/ATV tablets often results in poor ATV dissolution under acidic conditions, failing to meet regulatory requirements. This study aimed to improve ATV dissolution in acidic media through nanosuspension (NS) technology and microenvironmental pH modification. The experimental stages included preparation and characterization of ATV-NS, optimization of FDC EZT/ATV-nanocrystal tablets with pH modifiers, and evaluation of dissolution similarity (f2) against the innovator product Atozet®. ATV-NS was prepared via sonication and high-pressure homogenization using different stabilizers. Poloxamer 188-stabilized ATV-NS demonstrated optimal stability (particle size: 466.6 ± 8.9 nm; polydispersity index: 0.12 ± 0.10; zeta potential: −44.20 ± 0.06 mV) and significantly enhanced solubility (p < 0.05) compared with pure ATV. FDC EZT/ATV-nanocrystal tablets incorporating pH modifiers achieved f2 values for ATV of 52.36, 51.31, and 51.09 in NaCl/HCl pH 1.2, acetate buffer pH 4.5, and phosphate buffer pH 6.8, respectively. In contrast, EZT exhibited f2 values of 18.18, 16.72, and 14.66 (acceptable range: 50–100). Although complete profile similarity was not obtained for EZT, ATV dissolution in acidic media improved significantly (p < 0.05), supporting the feasibility of developing a bioequivalent generic FDC EZT/ATV tablet.

Förderung

  • Indonesia Endowment Fund for Education

Zitieren

APA

Azhary, D. P., Nugraha, Y. P., & Mauludin, R. (2026). Nanosuspension and Microenvironmental pH Modification to Enhance Atorvastatin Dissolution in Fixed-Dose Combination Ezetimibe/Atorvastatin Tablets. Biophysica, 6(3), 44. https://doi.org/10.3390/biophysica6030044

Vancouver

Azhary DP, Nugraha YP, Mauludin R. Nanosuspension and Microenvironmental pH Modification to Enhance Atorvastatin Dissolution in Fixed-Dose Combination Ezetimibe/Atorvastatin Tablets. Biophysica. 2026;6(3):44. doi:10.3390/biophysica6030044

BibTeX
@article{Azhary2026,
  author = {Azhary, Deny Puriyani and Nugraha, Yuda Prasetya and Mauludin, Rachmat},
  title = {Nanosuspension and Microenvironmental pH Modification to Enhance Atorvastatin Dissolution in Fixed-Dose Combination Ezetimibe/Atorvastatin Tablets},
  journal = {Biophysica},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {44},
  doi = {10.3390/biophysica6030044}
}
Kostenlos starten →